Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Sanara MedTech (SMTI) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Sanara MedTech (SMTI) over the last 13 years, with Q3 2025 value amounting to 0.07%.

  • Sanara MedTech's Return on Capital Employed fell 100.0% to 0.07% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.07%, marking a year-over-year decrease of 100.0%. This contributed to the annual value of 0.1% for FY2024, which is 200.0% down from last year.
  • According to the latest figures from Q3 2025, Sanara MedTech's Return on Capital Employed is 0.07%, which was down 100.0% from 0.09% recorded in Q2 2025.
  • In the past 5 years, Sanara MedTech's Return on Capital Employed registered a high of 0.06% during Q3 2024, and its lowest value of 0.34% during Q2 2022.
  • In the last 5 years, Sanara MedTech's Return on Capital Employed had a median value of 0.13% in 2024 and averaged 0.16%.
  • Its Return on Capital Employed has fluctuated over the past 5 years, first surged by 7000bps in 2021, then tumbled by -2200bps in 2022.
  • Over the past 5 years, Sanara MedTech's Return on Capital Employed (Quarter) stood at 0.24% in 2021, then dropped by -9bps to 0.26% in 2022, then skyrocketed by 73bps to 0.07% in 2023, then plummeted by -83bps to 0.13% in 2024, then skyrocketed by 44bps to 0.07% in 2025.
  • Its Return on Capital Employed stands at 0.07% for Q3 2025, versus 0.09% for Q2 2025 and 0.13% for Q1 2025.